Callitas Health Inc buy Quitte
Start price
30.06.17
/
50%
€0.41
Target price
01.01.18
€0.80
Performance (%)
-63.41%
End price
01.01.18
€0.15
Summary
This prediction ended on 01.01.18 with a price of €0.15. The BUY prediction by Quitte for Callitas Health Inc performed very badly with a performance of -63.41%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Callitas Health Inc | - | - | - | - |
| iShares Core DAX® | -1.611% | 3.135% | 15.880% | 15.652% |
| iShares Nasdaq 100 | -0.500% | 0.775% | 20.054% | 32.402% |
| iShares Nikkei 225® | -1.483% | 4.610% | 11.154% | -1.568% |
| iShares S&P 500 | -0.501% | 1.914% | 21.016% | 37.314% |
Comments by Quitte for this prediction
In the thread Callitas Health Inc diskutieren
Cash- Zunahme mit Abnehm-Produkt
einfach mal sehen, was die Trommelei bewirkt ......
DICKER VERSUCHSBALLON !! Hoffentlich lässt er nicht gleich wieder Luft ab ;-)
https://www.irw-press.com/de/news/neue-900-aktienchance-verzehnfacher-mit-dieser-biotech-aktie-spektakulaere-joint-ventures-in-wenigen-tagen-2-produkte-mit-fda-zulassung-besser-als-paion-und-evotec-top-biotech-aktienempfehlung-m-pharmaceutical-inc-ac-research_40237.html?isin=CA55346E2050
(Laufzeit überschritten)